Complex atheromatosis of the aortic arch in cerebral infarction

Current Cardiology Reviews

Volumn 6, Issue 3, 2010, Pages 184-193

  Capmany, Ramón Pujadas ^a   Ibañez, Montserrat Oliveras ^a   Pesquer, Xavier Jané ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Aortic arch atheroma; Complex aortic plaques; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; WARFARIN;

ANTICOAGULANT THERAPY; AORTA ARCH; ARTERY CALCIFICATION; ARTERY EMBOLISM; ARTICLE; ATHEROMA; ATHEROMATOSIS; ATHEROSCLEROTIC PLAQUE; AUTOPSY; BLOOD CLOT LYSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CIGARETTE SMOKING; DIABETES MELLITUS; ENDARTERECTOMY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; PATHOGENESIS; PRIORITY JOURNAL; STROKE; SUBCLAVIAN ARTERY; THORACIC AORTA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 77956551550     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310791658712     Document Type: Article

References (80)

1. Fisher CM. Occlusion of the internal carotid artery. Arch NeurolPsychiatry 1951; 65: 346-77
2. Pujadas-Capmany R, Arboix A, Casañas-Muñoz R, Anguera-Ferrando N. Specific cardiac disorders in 402 consecutive patients with ischaemic cardioembolic stroke. Int J Cardiol 2004; 95: 129-34
3. Cerebral Embolism Study Group. Immediate anticoagulation ofembolic stroke: brain hemorrhage and management options. Stroke 1984; 15: 779-89
4. Chamorro A, Vila N, Saiz A, Alday M, Tolosa E. Early anticoagulation after large cerebral embolic infarction: a safety study. Neurology 1995; 45: 861-5
5. Arboix A, Massons J, Oliveres M, García L, Titus F. Análisis de1.000 pacientes consecutivos con enfermedad cerebrovascularaguda: Registro de Patología Cerebrovascular de La Alianza. MedClin (Barc) 1993;101: 281-5
6. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The StrokeData Bank: design, methods, and baseline characteristics. Stroke 1988; 19: 547-54
7. Rothrock JF, Lyden PD, Brody ML, et al. An analysis of ischemicstroke in an urban southern California population: the University ofCalifornia, San Diego, Stroke Data Bank. Arch Intern Med 1993;153: 619-24
8. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA. Infarcts of undetermined cause: the NINCDS strokedata bank. Ann Neurol 1989; 25: 382-90
9. Davila-Roman VG, Barzilai B, Wareing TH, Murphy SF, Schechtman KB, Kouchoukos NT. Atherosclerosis of theascending aorta: prevalence and role as an independent predictor ofcerebrovascular events in cardiac patients. Stroke 1994; 25: 2010-6
10. Sen S, Oppenheimer SM, Lima J, Cohen B. Risk factors ofprogression of aortic atheroma in stroke and transient ischemicattack patients. Stroke 2002; 33: 930-5
11. Tribouilloy C, Peltier M, Colas L, Senni M, Ganry O, Rey JL, Lesbre JP. Fibrinogen is an independent marker for thoracic aorticatherosclerosis. Am J Cardiol 1998; 81: 321-6
12. Tribouilly C, Peltier M, Iannetta Peltier MC, Trojette F, Andrejak M, Lesbre JP. Plasma homocysteine ans severity of thoracic aorticatherosclerosis. Chest 2000; 118: 1685-9
13. Montgomery DH, Ververis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR. Natural history of severe atheromatous disease ofthe thoracic aorta: a transesophageal echocardiographic study. JAm Coll Cardiol 1996; 27: 95-101
14. Geraci A, Weinberger J. Natural history of aortic archatherosclerotic plaque. Neurology 2000; 54: 749-751
15. Flory CM. Arterial occlusions produced by eroded aorticatheromatous plaques. Am J Pathol 1945; 21: 549-58
16. Winter WJ. Atheromatous emboli: a cause of cerebral infarction. Arch Pathol 1957; 64: 137-42
17. Gore I, Collins DP. Spontaneous atheromatous embolization. Review of the literature and a report of 16 additional cases. Am JClin Pathol 1960; 33: 416-26
18. Tunick PA, Kronzon I. Protruding atherosclerotic plaque in theaortic arch of patients with systemic embolization: a new findingseen by transesophageal echocardiography. Am Heart J 1990: 120:658-60
19. Strong JP, Restrepo C, Guzman M. Coronary and aorticatherosclerosis in New Orleans II: comparison of lesions by age,sex, and race. Lab Invest 1978; 39: 364-9
20. Agmon Y, Khandheria BK, Meissner I, et al. Relation of coronaryartery disease and cerebrovascular disease with atherosclerosis ofthe thoracic aorta in the general population. Am J Cardiol 2002; 89:262-7
21. Amarenco P, Duyckaerts C, Tzourio C, Henin D, Bousser MG, Hauw JJ. The prevalence of ulcerated plaques in the aortic arch inpatients with stroke. N Engl J Med 1992; 326: 21-5
22. Khatibzadeh M, Mitush R, Stierle U, Gromoll B, Sheikhzadeh A. Aortic atherosclerotic plaques as a source of systemic embolism. JAm Coll Cardiol 1996; 27: 664-9
23. Pop G, Sutherland GR, Koudstaal PJ, Sit TW, de Jong G, Roelandt JR. Transesophageal echocardiography in the detection ofintracardiac embolic sources in patients with transient ischemicattacks. Stroke 1990; 21: 560-5
24. Fasseas P, Brilakis ES, Leybishkis B, et al. Association of carotidartery intima-media thickness with complex aortic atherosclerosisin patients with recent stroke. Angiology 2002; 53: 185-9.
25. Toyoda K, Yasaka M, Nagata S, Yamaguchi T. Aortogenicembolic stroke: a transesophageal echocardiographic approach. Stroke 1992; 23: 1056-61
26. Horowitz DR, Tuhrim S, Budd J, Goldman ME. Aortic plaque inpatients with brain ischemia: diagnosis by transesophagealechocardiography. Neurology 1992; 42: 1602-4
27. Tunick PA, Perez JL, Kronzon I. Protruding atheromas in thethoracic aorta and systemic embolization. Ann Intern Med 1991;115: 423-7
28. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA. Proximal aortic atheroma: an independent risk factor for cerebralischemia. Stroke 1995; 26: 218-24
29. Di Tullio MR, Sacco RL, Gersony D, et al. Aortic atheromas andacute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology 1996; 46: 1560-6
30. Di Tullio MR, Sacco RL, Savoia MT, Sciacca RR, Homma H. Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J 2000; 139: 329-36
31. Mitusch R, Tepe C, Stiere U, et al. Determinants of arterialembolism with special reference to atheromatous changes of the thoracic aorta. Z Kardiol 1995: 84: 198-204
32. Stone DA, Hawke MW, LaMonte M, et al. Ulcerated athero-sclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardio-graphic study. Am Heart J 1995; 130: 105-8
33. Matsumura Y, Osaki Y, Fuhui T, et al. Protruding atheroscleroticaortic plaques and dyslipidaemia correlation to subtypes of is chaemic stroke. Eur J Echocardiogr 2002; 3: 8-12
34. Nakayama K, Yamamuro Y, Ikuno Y, et al. Evaluation of patientswith cerebral infarction using transesophageal echocardiography:atherosclerotic changes in the thoracic aorta and the branches of the aortic arch. J Cardiol 1998; 32: 21-30
35. Nihoyannopulos P, Joshi J, Athenasopoulos G, Oakley CM. Detection of atherosclerotic lesions in the aorta by transesophagealechocardiography. Am J Cardiol 1993; 71: 1208-12
36. Tenenbaum A, Fisman EZ, Schneiderman J, et al. Disrupted mobile aortic plaques are a major risk factor for systemic embolismin the elderly. Cardiology 1998; 89: 246-51
37. Ferrari E, Vidal R, Chevallier T, Baudouy M. Atherosclerosis ofthe thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol 1999; 33: 1317-22
38. Kazui S, Levi CR, Jones EF, Quang L, Calafiore P, Doman GA. Risk factors for lacunar stroke: a case-control transesophagealechocardiographic study. Neurology 2000; 54: 1385-7
39. Karalis DG, Chandrasekaran K, Victor MF, Ross JR, Mintz GS. Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol 1991; 17: 73-8
40. Tunick PA, Lackner H, Katz ES, Culliford AT, Giangola G, Kronzon I. Multiple emboli from a large aortic arch thrombus in apatient with thrombotic diathesis. Am Heart J 1992; 124: 239-41
41. Tunick PA, Culliford A, Lamparello P, Kronzon I. Atheromatosis of the aortic arch as an occult source of multiple systemic emboli. Ann Intern Med 1991; 114: 391-2
42. Freedberg RS, Tunick PA, Culliford AT, Tatelbaum RJ, Kronzon I. Disappearance of a large intra-aortic mass in a patient with a priorsystemic embolization. Am Heart J 1993; 125: 1445-7
43. Bansal RC, Pauls GL, Shankel SW. Blue digit syndrome:transesophageal echocardiography identification of thoracic aortic plaque-related thrombi and successful outcome with warfarin. JAm Soc Echocardiogr 1993; 6: 319-23
44. Hausmann D, Gulba D, Bargheer K, Niedermeyer J, Comess KA, Daniel WG. Successful thrombolysis of an aortic arch thrombus in a patient after mesenteric embolism. N Engl J Med 1992; 327: 500-1
45. Meissner I, Khandheria BK, Sheps SG, et al. Atherosclerosis of the a orta: Risk factor, risk marker, or innocent bystander? Aprospective population-based transesophageal echocardiographicstudy. J Am Coll Cardiol 2004; 44: 1018-24
46. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331: 1474-9
47. Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I. High risk for vascular events in patients with protrudingaortic atheromas: a prospective study. J Am Coll Cardiol 1994; 23:1085-90
48. Mitusch R, Doherty C, Wucherpfenning H, et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997; 28: 36-9
49. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor forre current is chemic stroke. N Engl J Med 1996; 334: 1216-21
50. Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser MG, Amarenco P. Aortic plaque morphology and vascular events. Circulation 1997; 96: 3838-41
51. Nohara H, Shida T, Mukohara N, Obo H, Higami T. Ultrasonic plaque density of aortic atheroma and stroke in patients under going on-pump coronary by pass surgery. Ann Thorac Cardiovasc Surg 2004; 10: 235-40
52. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extra cellularlipid, macrophage, and smooth muscle cell content. Br Heart J 1993; 69: 377-81
53. Pujadas R, Arboix A, Anguera N, Oliveres M, Massons J, Comes E. Papel de las placas complejas de ateroma aórtico en larecurrencia del infarto cerebral de etiología incierta. Rev EspCardiol 2005; 58: 34-40
54. Schwammenthal E, Schwammenthal Y, Tanne D, et al. Transcutaneous detection of aortic arch atheromas by supraesternalharmonic imaging. J Am Coll Cardiol 2002; 39: 1127-32
55. Zaidat OO, Suarez JI, Hedrick D, et al. Reproducibility of transesophageal echocardiography in evaluating aortic atheroma instroke patients. Echocardiography 2005; 22: 326-30
56. Kramer CM, Cerilli LA, Hagspiel K, DiMaria JM, Epstein FH, Kern JA. Magnetic resonance imaging identifies the fibrous cap in the atherosclerotic abdominal aortic aneurysm. Circulation 2004;109: 1016-21
57. Rutt BK, Carke SE, Fayad ZA. Atherosclerotic plaquecharacterization by RM imaging. Curr Drug Targets CardiovascHaematol Disord 2004; 4: 147-59
58. Kramer CM. Magnetic resonance imaging to identify the high-riskplaque. Am J Cardiol 2002; 90: 15L-17L
59. Kutz SM, Lee V, Tunick PA, Krinsky G, Kronzon I. Atheromas ofthe thoracic aorta: a comparison of transesophageal echocar-diography and breath hold gadolinium-enhanced 3-D magneticresonance angiography. J Am Soc Echocardiogr 1999; 12: 582-5
60. Tenenbaum A, Garniek A, Shemesh J, et al. Dual-helical CT for detecting aortic atheromas as a source of stroke: comparison with transesophageal echocardiography. Radiology 1998; 208: 153-8
61. Tenenbaum A, Garniek A, Shemesh J, et al. Protruding aorticatheroma: is there a need for a new imaging modality? Isr MedAssoc J 2000: 2: 54
62. Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxy-glucose uptake in the aortic wall at PET/CT: possible finding foractive atherosclerosis. Radiology 2003; 229: 831-7
63. Ogawa M, Ishino S, Mukai T, et al. (18)-F-FDG accumulation inthe atherosclerotic plaques: immunohistochemical and PETimaging study. J Nucl Med 2004; 45: 1245-50
64. Muehrcke DD, Grima RA, Nissen SE, Cosgrove DM III. Recurrentcerebral vascular accidents are an indication for ascending aorticendarterectomy. Ann Thorac Surg 1996; 61: 1516-8
65. Arko FR, Fritcher S, Mettauer M, Patterson DE, Buckley CJ, Manning LG. Mobile atheroma of the aortic arch and the risk ofcarotid artery disease. Am J Surg 1999; 178: 206-8
66. Stern A, Tunick PA, Culliford AT, et al. Protruding aortic archatheromas: risk of stroke during heart surgery with and with outaortic arch endarterectomy. Am Heart J 1999; 138: 746-52
67. Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatininduces regression of human atherosclerotic lesions: two yearsfollow-up by high-resolution non-invasive magnetic resonanceimaging. Circulation 2002; 106: 2884-7
68. Heart Protection Study Collaborative Group. MRC/HeartProtection Study of cholesterol lowering with simvastatina in20.536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 7-22
69. Lewis SJ, Moye LA, Sacks FM, et al. Effect of pravastatin oncardiovascular events in older patients with myocadial infarctionand cholesterol levels in the average range: results of theCholesterol and Recurrent Events (CARE) trial. Ann Intern Med 1998; 129: 681-9
70. Tunick PA, Nayar AC, Goodkin GM, et al. Effect of treatment onthe incidence of stroke and other emboli in 519 patients with severeaortic plaque. Am J Cardiol 2002; 90: 1320-5
71. Lima JA, Desai MY, Steen AH, Warren WP, Gautam S, Lai S. Statin-induced cholesterol lowering and plaque regression after 6months of magnetic resonance imaging-monitored therapy. Circulation 2004; 110: 2336-41
72. Corti R, Fuster V, Fayad ZA, et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atheroscelerotic lesions: a prospective, randomized, double-blindtrial with high-resolution magnetic resonance imaging. J Am CollCardiol 2005; 46: 106-12
73. Yonemura A, Momiyama Y, Fayad ZA, et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by non-invasive magnetic resonance imaging. J Am CollCardiol 2005; 45: 733-42
74. PROGRESS Collaborative Group. Randomized trial of perindopril-based blood-pressure-lowering regimen among 6.105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358:1033-41
75. Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aorticatheroma and systemic emboli: efficacy of anticoagulation andinfluence of plaque morphology on recurrent stroke. J Am CollCardiol 1998; 31:134-8
76. Antiplatelet trialists' collaboration. Collaborative overview ofrandomized trials of antiplatelet therapy. Prevention of death,myocardial infarction, and stroke by prolonged antiplatelet therapyin various categories of patients. BMJ 1994; 308: 81-106
77. The CAPRIE study. A randomised, blinded, trial of clopidogrelversus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39
78. Bhatt DL, Fox KAA, Hacke W, et al. Clopidogrel and aspirinversus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-17
79. Diener HC, Bogousslavsky J, Brass LM, et al. Aspirin andclopidogrel compared with clopidogrel alone after recent ischaemicstroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004;364: 331-7
80. Aortic Arch Related Cerebral Hazard Trial (ARCH) Website.(http://www.strokecenter.org/trials). Data accessed July 16, 2009.